Grayscale seeks SEC approval to convert its crypto ETF fund into a public ETF with diversified holdings in Bitcoin, Ether, XRP, and ADA.

MADRID, March 18 (Reuters) - Spain's BBVA (BBVA.MC), opens new tab remained confident that its hostile takeover bid for smaller rival Sabadell (SABE.MC), opens new tab will be approved by ...

Coach Travis Green remains optimistic about Tkachuk's availability for the crucial Atlantic Division matchup, which is essential as the Senators aim to extend their winning streak. Image via Imagn ...

Crypto asset manager 21Shares is set to liquidate two actively managed exchange-traded funds (ETFs) tied to bitcoin and ether futures amid a wider market downturn. The funds slated for liquidation ...

(Reuters) - The U.S. Securities and Exchange Commission could approve exchange traded funds (ETFs) tied to the spot price of ether ... and Grayscale Investments, are seeking SEC approval for ...

Get Our Latest Research Report on ONCY Oncolytics Biotech Stock Up 0.3 % NASDAQ ONCY opened at $0.63 on Thursday. Oncolytics Biotech has a 52 week low of $0.58 and a 52 week high of $1.53. The ...

The U.S. Securities and Exchange Commission has postponed its decision on several exchange-traded funds tied to Ripple’s XRP (XRP), Solana (SOL), Litecoin (LTC), and Dogecoin (DOGE), delaying clarity ...

21Shares, Bitwise Invest, Canary Funds, Grayscale ... the 64th alt/meme coin ETF filing that is now awaiting approval btw.” Franklin Templeton’s filing signals optimism that the SEC may ...

Grayscale’s application for a spot ... according to Bloomberg analysts Eric Balchunas and James Seyffart, XRP ETFs have a 65–75% chance of being approved in 2025. Market sentiment also remains ...

This doesn't change our (relatively high) odds of approval. Also note that the final deadlines… — James Seyffart (@JSeyff) March 11, 2025 Additionally, fellow analyst Eric Balchunas noted that ...

For the XRP ETF, the SEC has until mid-October to make a final decision. Investors are waiting to see if this trend of positive regulatory changes continues. While approval is still uncertain, market ...